SPL

0.00%

9.7¢ starpharma holdings limited

What is the one word we all need?, page-60

First 60 Last

Share
Profile

Follow
antibotter

12,902 Posts.

1440

17/03/17

17:32

Post #: 23440890
Share

Originally posted by matthias208 ↑

What's my agenda? Ha!! Why assume I have an agenda at all? Do you see everything in terms of agenda? What's your agenda? Or are you just insane? I'll tell you what my deal is because I think a bit of honesty and objectivity is needed here in this forum given the fact that you've dominated the threads and posts of SPL here for years with nothing more than insipid naive optimism. Flinching at everything to do with SPL and getting excited at every little insignificant thing about SPL. You seem to be more devoted to SPL than the most devout Christian or Muslim is to their religion. I accept that every stock forum has one of these obsessive compulsive devotees (I've seen plenty of them) but of the dozen or so stocks I follow on Hotcopper, you probably take the cake! You're insane! Do you comment anywhere else? Do you own any other stocks?

1. Held SPL for near a decade. Bought in at 27c pre-2010 (can't remember the year). Bought more throughout the years but sold last lot of shares last year (can't remember when exactly). Should have sold it all when it was above $1 but didn't. Should have sold it all after failure of vivagel phase 3 in 2012 but still held onto hope and delusion for another 3 years! Still made a small profit but could have been so much more if I didn't have rose coloured glasses on. But you live and learn!

2. So you could say that I ran out of P and P but I think I've given more than enough P and P to this fricken stock. And I don't do short selling, period.

3. And no way in hell will I ever consider hopping back on board unless something drastic changes or if SP fluctuates well below 60c (to get a quick 20% profit). But I've got bigger fish to fry. SPL is not the only stock out there you know? Do you know that?! There are plenty of other biotech companies with multiple drug candidates, with just as much promise, if not more, and well into clinical trial phases, with major commercial partnerships, regulatory approvals etc etc etc. And they still struggle! And shareholders still wait and wait and P and P!... I've come to appreciate the significance of opportunity cost a lot more as the years go by and as I reflect on how long I've waited around for this and other stocks. You have to be willing to ask yourself what else you could be doing with your money. Have you ever asked yourself this?

4. My agenda? As I said in my initial post I kept getting these alerts for this thread and so I decided to have a look and to my bemusement and amusement I saw that nothing had changed. SP still languishing in the 60s and 70s and you and your arch nemesis still going at it. But I'm not a sadist like your arch nemesis is. I don't derive pleasure or schadenfruede from any of this.

Expand

Matthias - so you bought in 2010 and
sold out completely 8 plus months ago
6 years plus
I have held for 3 plus years. And yes price has fluctuated - however I elected to hold - looking at bigger picture like the Allan Grays of this world. I am not naive - nor wear "special glasses"
Come back in another year and let me hear your thoughts then.
Thankful for the warning
I like taking calculated risks for high returns - which from my perspective will be reaped in the very very near future

SPL Price at posting: 64.5¢ Sentiment: Buy Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

BUX

Buxton projects new graphite province discovery at WA Narryer play

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

There are more pages in this discussion • 48 more messages in this thread...

First 60 Last

Add SPL (ASX) to my watchlist

(20min delay)
Last 9.7¢		Change 0.000(0.00%)		Mkt cap ! $40.48M

Open	High	Low	Value	Volume
9.9¢	9.9¢	9.5¢	$35.24K	364.0K

Buyers (Bids)

No.	Vol.	Price($)
3	18326	9.5¢

Sellers (Offers)

Price($)	Vol.	No.
9.8¢	15262	2

View Market Depth

No.	Vol.	Price($)
2	8326	0.095
3	160000	0.094
2	134306	0.092
3	81442	0.090
1	30000	0.089

Price($)	Vol.	No.
0.098	5000	1
0.100	38876	3
0.105	199768	2
0.110	168286	9
0.115	85453	2

Last trade - 16.10pm 04/10/2024 (20 minute delay)

SPL (ASX) Chart

What is the one word we all need?, page-60

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Buxton projects new graphite province discovery at WA Narryer play

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

BCI reaches close of funding facility for salt-first part of Mardie project

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

What is the one word we all need?, page-60

Top Stories

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Buxton projects new graphite province discovery at WA Narryer play

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

BCI reaches close of funding facility for salt-first part of Mardie project

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News